ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The Sarepta mess"
Episode Synopsis
In the last two weeks, Sarepta has been threatened by the FDA with having its drug pulled, refused to do so, then capitulated, and then won a reversal by the regulator. We'll talk with R.W. Baird analyst Brian Skorney, who has followed the company's ups and downs for years, and what this latest twist tells us about the company's future, how this FDA is operating, and the power of patient and political pressure.
More episodes of the podcast Post-Hoc Live
The plan to make more custom CRISPR therapies — w Kiran Musunuru & Rebecca Ahrens-Nicklas
03/11/2025
The fight over Metsera
03/11/2025
Breaking down the XBI — with Josh Schimmer
10/09/2025
Choosing the Endpoints 11
03/09/2025
In God we trust